RE: Rns24 Apr 2025 07:07
Outlook and guidance
In FY25, the benefits of our new commercial model will become increasingly apparent. As such, we continue to expect
FY25 gross margin improvement of at least 300 bps to more than 46%, and adjusted EBITDA growth of at least 60%
to £130m to £150m, post TSTM JV impact9
. We expect FY25 free cash flow to be broadly neutral, with capex of
c.£130m10 and cash interest of c.£35m. We will continue to focus on creating a solid and profitable base upon which
we will drive sustainably profitable revenue growth. For FY25, we expect revenue growth towards the bottom end of
consensus range. FY25 GMV growth expected to be 1-2ppts better than revenue growth as a result of our FF models
scaling.
We have made substantial progress on our operational cost structure and as such we feel confident that for FY26 we
will generate meaningful free cash flow.
Our core focus remains sustainable, profitable growth. In the mid-term we continue to expect to generate adjusted
EBITDA sustainably ahead of capex, interest, tax and leases, with revenue growth and an adjusted EBITDA margin of
c.8%. Our new commercial model can drive materially higher gross margin towards c.50% through higher full-price
sales mix and flexible stock models, which also benefit our inventory days. Our focus on efficient capital allocation will
bring our capex down to 3% to 4% of sales, over time, we anticipate that our improving profitability and cash flow will
also reduce our net debt and interest levels